SCHEMBL5607214

SCHEMBL5607214

CCCOC(=O)C(=Cc1ccc(OCc2ccccc2)cc1)OCCC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.64
KDM4E B2RXH2 3/20 0.50
GSK3B P49841 3/20 0.50
BACE1 P56817 3/20 0.50
MAPT P10636 2/20 0.50
NPC1 O15118 1/20 0.50
GAA P10253 1/20 0.50
RAB9A P51151 1/20 0.50
ALDH1A1 P00352 2/20 0.48
MAOB P27338 2/20 0.48
KMT2A Q03164 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
MEN1 O00255 1/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
LMNA P02545 1/20 0.47
NR4A1 P22736 1/20 0.47
NR4A2 P43354 1/20 0.47
NR4A3 Q92570 1/20 0.47
SLC5A1 P13866 1/20 0.46
SLC5A2 P31639 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5607211 1.00 NR1H4 (0.64) NR1H4KDM4EGSK3BBACE1MAPT
SCHEMBL5606966 0.96 NR1H4 (0.60) NR1H4KDM4EGSK3BBACE1MAPT
SCHEMBL5607391 0.96 NR1H4 (0.60) NR1H4KDM4EGSK3BBACE1MAPT
SCHEMBL5606970 0.96 NR1H4 (0.60) NR1H4KDM4EGSK3BBACE1MAPT
SCHEMBL5607397 0.96 NR1H4 (0.60) NR1H4KDM4EGSK3BBACE1MAPT
SCHEMBL5607439 0.95 NR1H4 (0.72) NR1H4KDM4EGSK3BBACE1MAPT
SCHEMBL5607430 0.95 NR1H4 (0.72) NR1H4KDM4EGSK3BBACE1MAPT
SCHEMBL5607535 0.95 NR1H4 (0.68) NR1H4KDM4EGSK3BBACE1MAPT
SCHEMBL5607538 0.95 NR1H4 (0.68) NR1H4KDM4EGSK3BBACE1MAPT
SCHEMBL5607682 0.94 NR1H4 (0.62) NR1H4KDM4EGSK3BBACE1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
EP-1687250-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS Takasago International Corporation (JP) 2006-08-09 EP disclosed
WO-2005051882-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids ALDH1A2, ALDH1A3, GRHPR NR1H4 220/4885KDM4E 3298/4885GSK3B 2848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.